Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?

<p>Abstract</p> <p>Background</p> <p>Sporadic renal cell carcinoma (RCC) is rare in young adults. In the present retrospective study we reviewed clinicopathological features and disease specific survival rates in young patients (≤45 years) with RCC and compared them to...

Full description

Bibliographic Details
Main Authors: Junker Kerstin, Hammerschmied Christine, Burger Maximilian, Otto Wolfgang, Denzinger Stefan, Hartmann Arndt, Wieland Wolf F, Walter Bernhard
Format: Article
Language:English
Published: BMC 2007-02-01
Series:World Journal of Surgical Oncology
Online Access:http://www.wjso.com/content/5/1/16
_version_ 1818823252211924992
author Junker Kerstin
Hammerschmied Christine
Burger Maximilian
Otto Wolfgang
Denzinger Stefan
Hartmann Arndt
Wieland Wolf F
Walter Bernhard
author_facet Junker Kerstin
Hammerschmied Christine
Burger Maximilian
Otto Wolfgang
Denzinger Stefan
Hartmann Arndt
Wieland Wolf F
Walter Bernhard
author_sort Junker Kerstin
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Sporadic renal cell carcinoma (RCC) is rare in young adults. In the present retrospective study we reviewed clinicopathological features and disease specific survival rates in young patients (≤45 years) with RCC and compared them to old patients (≥75 years) with RCC.</p> <p>Methods</p> <p>Between 1992 and 2005 a total of 1042 patients were treated for RCC at our institution. We found 70 patients 45 years or younger (YP) and 150 patients 75 years or older (OP) at time of diagnosis. There were no differences in therapeutical approaches between both groups. Clinical and biologic parameters at diagnosis were compared and subjected to uni- and multivariate analysis to study cancer specific survival and progression rate. Mean postoperative follow-up in both groups was 50.1 months.</p> <p>Results</p> <p>Mean age was 39 years in YP and 80 years in OP, respectively. YP demonstrated significantly lower stage (pT1-pT2 N0 M0, p = 0.03), lower tumor grade (p = 0.01) and higher male-to-female ratio (p < 0.001). The rate of lymph node metastases or distant metastatic disease at presentation did not differ significantly between both groups. In multivariate analysis young age was independently associated with a higher 5-year cancer specific survival (95.2% vs. 72.3%, p = 0.009) and a lower 5-year progression rate (11.3% vs. 42.5%, p = 0.002).</p> <p>Conclusion</p> <p>Sporadic RCC in young patients have lower tumor stages and grades and a better outcome compared to elderly. Age≤45 years was an independent prognostic factor for survival and progression.</p>
first_indexed 2024-12-18T23:37:01Z
format Article
id doaj.art-f43d3c4cb25a4496bd262238b2d18076
institution Directory Open Access Journal
issn 1477-7819
language English
last_indexed 2024-12-18T23:37:01Z
publishDate 2007-02-01
publisher BMC
record_format Article
series World Journal of Surgical Oncology
spelling doaj.art-f43d3c4cb25a4496bd262238b2d180762022-12-21T20:47:31ZengBMCWorld Journal of Surgical Oncology1477-78192007-02-01511610.1186/1477-7819-5-16Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?Junker KerstinHammerschmied ChristineBurger MaximilianOtto WolfgangDenzinger StefanHartmann ArndtWieland Wolf FWalter Bernhard<p>Abstract</p> <p>Background</p> <p>Sporadic renal cell carcinoma (RCC) is rare in young adults. In the present retrospective study we reviewed clinicopathological features and disease specific survival rates in young patients (≤45 years) with RCC and compared them to old patients (≥75 years) with RCC.</p> <p>Methods</p> <p>Between 1992 and 2005 a total of 1042 patients were treated for RCC at our institution. We found 70 patients 45 years or younger (YP) and 150 patients 75 years or older (OP) at time of diagnosis. There were no differences in therapeutical approaches between both groups. Clinical and biologic parameters at diagnosis were compared and subjected to uni- and multivariate analysis to study cancer specific survival and progression rate. Mean postoperative follow-up in both groups was 50.1 months.</p> <p>Results</p> <p>Mean age was 39 years in YP and 80 years in OP, respectively. YP demonstrated significantly lower stage (pT1-pT2 N0 M0, p = 0.03), lower tumor grade (p = 0.01) and higher male-to-female ratio (p < 0.001). The rate of lymph node metastases or distant metastatic disease at presentation did not differ significantly between both groups. In multivariate analysis young age was independently associated with a higher 5-year cancer specific survival (95.2% vs. 72.3%, p = 0.009) and a lower 5-year progression rate (11.3% vs. 42.5%, p = 0.002).</p> <p>Conclusion</p> <p>Sporadic RCC in young patients have lower tumor stages and grades and a better outcome compared to elderly. Age≤45 years was an independent prognostic factor for survival and progression.</p>http://www.wjso.com/content/5/1/16
spellingShingle Junker Kerstin
Hammerschmied Christine
Burger Maximilian
Otto Wolfgang
Denzinger Stefan
Hartmann Arndt
Wieland Wolf F
Walter Bernhard
Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
World Journal of Surgical Oncology
title Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
title_full Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
title_fullStr Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
title_full_unstemmed Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
title_short Sporadic renal cell carcinoma in young and elderly patients: are there different clinicopathological features and disease specific survival rates?
title_sort sporadic renal cell carcinoma in young and elderly patients are there different clinicopathological features and disease specific survival rates
url http://www.wjso.com/content/5/1/16
work_keys_str_mv AT junkerkerstin sporadicrenalcellcarcinomainyoungandelderlypatientsaretheredifferentclinicopathologicalfeaturesanddiseasespecificsurvivalrates
AT hammerschmiedchristine sporadicrenalcellcarcinomainyoungandelderlypatientsaretheredifferentclinicopathologicalfeaturesanddiseasespecificsurvivalrates
AT burgermaximilian sporadicrenalcellcarcinomainyoungandelderlypatientsaretheredifferentclinicopathologicalfeaturesanddiseasespecificsurvivalrates
AT ottowolfgang sporadicrenalcellcarcinomainyoungandelderlypatientsaretheredifferentclinicopathologicalfeaturesanddiseasespecificsurvivalrates
AT denzingerstefan sporadicrenalcellcarcinomainyoungandelderlypatientsaretheredifferentclinicopathologicalfeaturesanddiseasespecificsurvivalrates
AT hartmannarndt sporadicrenalcellcarcinomainyoungandelderlypatientsaretheredifferentclinicopathologicalfeaturesanddiseasespecificsurvivalrates
AT wielandwolff sporadicrenalcellcarcinomainyoungandelderlypatientsaretheredifferentclinicopathologicalfeaturesanddiseasespecificsurvivalrates
AT walterbernhard sporadicrenalcellcarcinomainyoungandelderlypatientsaretheredifferentclinicopathologicalfeaturesanddiseasespecificsurvivalrates